CD244 represents a new therapeutic target in head and neck squamous cell carcinoma
Laura Agresta(Cincinnati Children's Hospital Medical Center), Edith M. Janssen(Springhouse), Rachel Cantrell(Cincinnati Children's Hospital Medical Center), Cassandra M. Hennies(Cincinnati Children's Hospital Medical Center), Sara Szabo(Cincinnati Children's Hospital Medical Center), Kristin Lampe(Cincinnati Children's Hospital Medical Center), Kasper Hoebe(Johnson & Johnson (United States)), Maria Lehn(Cincinnati Children's Hospital Medical Center), Trisha M. Wise‐Draper(University of Cincinnati), Laura Conforti(University of Cincinnati)
Cited by 54
Related Papers
Wallerian degeneration: an emerging axon death pathway linking injury and disease
|Nature reviews. Neuroscience|2014|627
Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene
|Nature Neuroscience|2001|616
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
|Annals of Oncology|2021|328
A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration
|Cell Death and Differentiation|2014|263